pd 98059 has been researched along with Sclerosis, Systemic in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, HJ | 1 |
Song, SB | 1 |
Choi, JM | 1 |
Kim, KM | 1 |
Cho, BK | 1 |
Cho, DH | 1 |
Park, HJ | 1 |
Yamane, K | 1 |
Ihn, H | 1 |
Kubo, M | 1 |
Tamaki, K | 1 |
2 other studies available for pd 98059 and Sclerosis, Systemic
Article | Year |
---|---|
IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway.
Topics: Cells, Cultured; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Dermi | 2010 |
Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
Topics: Activin Receptors, Type I; Cells, Cultured; Chromones; Collagen Type I; Enzyme Inhibitors; Fibroblas | 2002 |